Jefferies lowered the firm’s price target on Progyny (PGNY) to $19 from $24 and keeps a Buy rating on the shares. The firm is lowering estimates to reflect selling season results – 1.1M member adds offset by about 700,000 from a previously announced customer loss – while also taking “a more conservative approach” to modeling utilization/mix in Q4 and FY25.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PGNY: